drugset / Trial / NCT03457662
Sonodynamic Therapy Manipulates Atherosclerosis Regression Trial on Patients With PAD and Claudication
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this trial is to evaluate the safety and efficacy of sonodynamic therapy (SDT) on reducing atherosclerotic plaques inflammation among patients with symptomatic femoropopliteal peripheral artery disease.
Timeline
- Start
- 2018-03-15
- Primary completion
- 2018-12-18
- Completion
- 2019-04-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sinoporphyrin sodium | Other / unclassified | 0.2 mg/kg | Intravenous |